Why the study?
The study was conducted to examine serum angiopoietin-2 in relation to MIAC syndrome and its predictive role in outcomes of peritoneal dialysis patients.
Population
324 chronic peritoneal dialysis patients
Comparison
Serum angiopoietin-2 levels across tertiles
Design
Prospective observational study
Authors
Loading...
Angpt-2 may refine CV risk stratification in PD; hypothesis-generating and requires prospective validation before clinical use.
Elevated serum Angpt-2 is an independent predictor of fatal and nonfatal cardiovascular events in patients undergoing peritoneal dialysis, suggesting its utility for cardiovascular risk stratification.
Yang et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: